Tasca, Karen Ingrid <br/><br/>
The Initial Months of Antiretroviral Therapy and Its Influence on AGEs, HMGB1, and sRAGE Levels in Asymptomatic HIV-Infected Individuals.  [electronic resource] 

 -  Mediators of inflammation  2016 
 - 2909576 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1466-1861 
<br/><br/><label>Standard No.: </label>10.1155/2016/2909576  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-Retroviral Agents--therapeutic use<br/>Biomarkers--blood<br/>C-Reactive Protein--metabolism<br/>CD4-Positive T-Lymphocytes--cytology<br/>Comorbidity<br/>Female<br/>Glycation End Products, Advanced--blood<br/>HIV Infections--blood<br/>HMGB1 Protein--blood<br/>Humans<br/>Inflammation<br/>Interleukin-10--blood<br/>Interleukin-6--blood<br/>Interleukin-8--blood<br/>Longitudinal Studies<br/>Male<br/>Middle Aged<br/>Receptor for Advanced Glycation End Products--blood<br/>Triglycerides--metabolism<br/>Young Adult